-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a number of domestic star pharmaceutical companies have gathered together to produce esomeprazole magnesium enteric-coated dry suspension.
Chengdu Yuandong Biotechnology submitted an application for 3 types of generic listing on November 29, Jiangsu Aosaikang Pharmaceutical|Yangzhou City Sanyao Pharmaceutical also submitted an application for 3 types of generic marketing today (December 1).
This over 5 billion anti-peptic ulcer blockbuster children's dosage form has attracted market attention
.
Chengdu Yuandong Biotechnology submitted an application for 3 types of generic listing on November 29, Jiangsu Aosaikang Pharmaceutical|Yangzhou City Sanyao Pharmaceutical also submitted an application for 3 types of generic marketing today (December 1).
This over 5 billion anti-peptic ulcer blockbuster children's dosage form has attracted market attention
.
Figure 1: The situation of companies that recently reported the production of esomeprazole magnesium enteric-coated dry suspension
Source: CDE official website
Figure 2: Sales Trend of Esomeprazole (Unit: Ten Thousand Yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
Esomeprazole is a single S isomer of omeprazole, and it is also the first drug with only one optical isomer among proton pump inhibitors.
Compared with omeprazole and R-isomer, Esomeprazole has a low liver first-pass clearance effect, a slow intrinsic clearance rate, a high AUC value, a high and long-lasting active drug concentration in the plasma, and an enhanced effect on the proton pump and inhibition of gastric acid secretion
.
According to data from Meinnet.
com, the sales of terminal esomeprazole in Chinese urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) in 2020 will exceed 5 billion yuan, and will be treated in 2021H1 In the TOP list of peptic ulcer drugs , esomeprazole rose to third place, with a growth rate of up to 20%
.
Compared with omeprazole and R-isomer, Esomeprazole has a low liver first-pass clearance effect, a slow intrinsic clearance rate, a high AUC value, a high and long-lasting active drug concentration in the plasma, and an enhanced effect on the proton pump and inhibition of gastric acid secretion
.
According to data from Meinnet.
com, the sales of terminal esomeprazole in Chinese urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) in 2020 will exceed 5 billion yuan, and will be treated in 2021H1 In the TOP list of peptic ulcer drugs , esomeprazole rose to third place, with a growth rate of up to 20%
.
At present, the best-selling dosage forms of esomeprazole on the domestic market include injections, enteric-coated tablets and enteric-coated capsules, and there is no enteric-coated dry suspension
.
Esomeprazole magnesium enteric-coated dry suspension is a child- specific proton pump inhibitor approved by the FDA .
It has stable storage, accurate dosage, convenient administration, and good taste, which greatly improves the compliance of children.
Sex
.
.
Esomeprazole magnesium enteric-coated dry suspension is a child- specific proton pump inhibitor approved by the FDA .
It has stable storage, accurate dosage, convenient administration, and good taste, which greatly improves the compliance of children.
Sex
.
Table 1: Application status of esomeprazole magnesium enteric-coated dry suspension currently under review
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Beimei Pharmaceuticals and Cipla Pharmaceuticals of India signed an exclusive license agreement in China for esomeprazole magnesium enteric-coated dry suspension in October 2020, and the application for the import of imitation marketing was undertaken by CDE in April 2021.
Currently under review and approval
.
Zhejiang Erying Pharmaceuticals | Zhejiang Jianfeng Pharmaceuticals, Shanghai Ambisheng Pharmaceutical Technology | Qingdao Baiyang Pharmaceuticals have submitted three types of generic listing applications in domestic pharmaceutical companies.
After Osaikang and Yuandong entered the market, the domestic The dispute over the first imitation has become more fierce, and we will wait and see whether the imported imitation will be approved first or the domestic first imitation will appear first
.
Currently under review and approval
.
Zhejiang Erying Pharmaceuticals | Zhejiang Jianfeng Pharmaceuticals, Shanghai Ambisheng Pharmaceutical Technology | Qingdao Baiyang Pharmaceuticals have submitted three types of generic listing applications in domestic pharmaceutical companies.
After Osaikang and Yuandong entered the market, the domestic The dispute over the first imitation has become more fierce, and we will wait and see whether the imported imitation will be approved first or the domestic first imitation will appear first
.
In addition, it is worth noting that Esomeprazole Magnesium Enteric-coated Dry Suspension is expected to become Yuandong Bio's first drug in the field of anti-peptic ulcer
.
.
Source: CDE official website, Minet database
Statistics are as of December 1.
Please correct me if there are any errors or omissions
.
Please correct me if there are any errors or omissions
.
Recently, a number of domestic star pharmaceutical companies have gathered together to produce esomeprazole magnesium enteric-coated dry suspension.
Chengdu Yuandong Biotechnology submitted an application for 3 types of generic listing on November 29, Jiangsu Aosaikang Pharmaceutical|Yangzhou City Sanyao Pharmaceutical also submitted an application for 3 types of generic marketing today (December 1).
This over 5 billion anti-peptic ulcer blockbuster children's dosage form has attracted market attention
.
Chengdu Yuandong Biotechnology submitted an application for 3 types of generic listing on November 29, Jiangsu Aosaikang Pharmaceutical|Yangzhou City Sanyao Pharmaceutical also submitted an application for 3 types of generic marketing today (December 1).
This over 5 billion anti-peptic ulcer blockbuster children's dosage form has attracted market attention
.
Figure 1: The situation of companies that recently reported the production of esomeprazole magnesium enteric-coated dry suspension
Source: CDE official website
Figure 2: Sales Trend of Esomeprazole (Unit: Ten Thousand Yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
Esomeprazole is a single S isomer of omeprazole, and it is also the first drug with only one optical isomer among proton pump inhibitors.
Compared with omeprazole and R-isomer, Esomeprazole has a low liver first-pass clearance effect, a slow intrinsic clearance rate, a high AUC value, a high and long-lasting active drug concentration in the plasma, and an enhanced effect on the proton pump and inhibition of gastric acid secretion
.
According to data from Meinnet.
com, the sales of terminal esomeprazole in Chinese urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) in 2020 will exceed 5 billion yuan, and will be treated in 2021H1 In the TOP list of peptic ulcer drugs , esomeprazole rose to third place, with a growth rate of up to 20%
.
Compared with omeprazole and R-isomer, Esomeprazole has a low liver first-pass clearance effect, a slow intrinsic clearance rate, a high AUC value, a high and long-lasting active drug concentration in the plasma, and an enhanced effect on the proton pump and inhibition of gastric acid secretion
.
According to data from Meinnet.
com, the sales of terminal esomeprazole in Chinese urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) in 2020 will exceed 5 billion yuan, and will be treated in 2021H1 In the TOP list of peptic ulcer drugs , esomeprazole rose to third place, with a growth rate of up to 20%
.
At present, the best-selling dosage forms of esomeprazole on the domestic market include injections, enteric-coated tablets and enteric-coated capsules, and there is no enteric-coated dry suspension
.
Esomeprazole magnesium enteric-coated dry suspension is a child- specific proton pump inhibitor approved by the FDA .
It has stable storage, accurate dosage, convenient administration, and good taste, which greatly improves the compliance of children.
Sex
.
.
Esomeprazole magnesium enteric-coated dry suspension is a child- specific proton pump inhibitor approved by the FDA .
It has stable storage, accurate dosage, convenient administration, and good taste, which greatly improves the compliance of children.
Sex
.
Table 1: Application status of esomeprazole magnesium enteric-coated dry suspension currently under review
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Beimei Pharmaceuticals and Cipla Pharmaceuticals of India signed an exclusive license agreement in China for esomeprazole magnesium enteric-coated dry suspension in October 2020, and the application for the import of imitation marketing was undertaken by CDE in April 2021.
Currently under review and approval
.
Zhejiang Erying Pharmaceuticals | Zhejiang Jianfeng Pharmaceuticals, Shanghai Ambisheng Pharmaceutical Technology | Qingdao Baiyang Pharmaceuticals have submitted three types of generic listing applications in domestic pharmaceutical companies.
After Osaikang and Yuandong entered the market, the domestic The dispute over the first imitation has become more fierce, and we will wait and see whether the imported imitation will be approved first or the domestic first imitation will appear first
.
Currently under review and approval
.
Zhejiang Erying Pharmaceuticals | Zhejiang Jianfeng Pharmaceuticals, Shanghai Ambisheng Pharmaceutical Technology | Qingdao Baiyang Pharmaceuticals have submitted three types of generic listing applications in domestic pharmaceutical companies.
After Osaikang and Yuandong entered the market, the domestic The dispute over the first imitation has become more fierce, and we will wait and see whether the imported imitation will be approved first or the domestic first imitation will appear first
.
In addition, it is worth noting that Esomeprazole Magnesium Enteric-coated Dry Suspension is expected to become Yuandong Bio's first drug in the field of anti-peptic ulcer
.
.
Source: CDE official website, Minet database
Statistics are as of December 1.
Please correct me if there are any errors or omissions
.
Please correct me if there are any errors or omissions
.
Recently, a number of domestic star pharmaceutical companies have gathered together to produce esomeprazole magnesium enteric-coated dry suspension.
Chengdu Yuandong Biotechnology submitted an application for 3 types of generic listing on November 29, Jiangsu Aosaikang Pharmaceutical|Yangzhou City Sanyao Pharmaceutical also submitted an application for 3 types of generic marketing today (December 1).
This over 5 billion anti-peptic ulcer blockbuster children's dosage form has attracted market attention
.
Chengdu Yuandong Biotechnology submitted an application for 3 types of generic listing on November 29, Jiangsu Aosaikang Pharmaceutical|Yangzhou City Sanyao Pharmaceutical also submitted an application for 3 types of generic marketing today (December 1).
This over 5 billion anti-peptic ulcer blockbuster children's dosage form has attracted market attention
.
Figure 1: The situation of companies that recently reported the production of esomeprazole magnesium enteric-coated dry suspension
Source: CDE official website
Figure 2: Sales Trend of Esomeprazole (Unit: Ten Thousand Yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
Esomeprazole is a single S isomer of omeprazole, and it is also the first drug with only one optical isomer among proton pump inhibitors.
Compared with omeprazole and R-isomer, Esomeprazole has a low liver first-pass clearance effect, a slow intrinsic clearance rate, a high AUC value, a high and long-lasting active drug concentration in the plasma, and an enhanced effect on the proton pump and inhibition of gastric acid secretion
.
According to data from Meinnet.
com, the sales of terminal esomeprazole in Chinese urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) in 2020 will exceed 5 billion yuan, and will be treated in 2021H1 In the TOP list of peptic ulcer drugs , esomeprazole rose to third place, with a growth rate of up to 20%
.
Hospital hospital hospital medicine medicine medicineCompared with omeprazole and R-isomer, Esomeprazole has a low liver first-pass clearance effect, a slow intrinsic clearance rate, a high AUC value, a high and long-lasting active drug concentration in the plasma, and an enhanced effect on the proton pump and inhibition of gastric acid secretion
.
According to data from Meinnet.
com, the sales of terminal esomeprazole in Chinese urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) in 2020 will exceed 5 billion yuan, and will be treated in 2021H1 In the TOP list of peptic ulcer drugs , esomeprazole rose to third place, with a growth rate of up to 20%
.
At present, the best-selling dosage forms of esomeprazole on the domestic market include injections, enteric-coated tablets and enteric-coated capsules, and there is no enteric-coated dry suspension
.
Esomeprazole magnesium enteric-coated dry suspension is a child- specific proton pump inhibitor approved by the FDA .
It has stable storage, accurate dosage, convenient administration, and good taste, which greatly improves the compliance of children.
Sex
.
Child, child, kid.
Esomeprazole magnesium enteric-coated dry suspension is a child- specific proton pump inhibitor approved by the FDA .
It has stable storage, accurate dosage, convenient administration, and good taste, which greatly improves the compliance of children.
Sex
.
Table 1: Application status of esomeprazole magnesium enteric-coated dry suspension currently under review
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Beimei Pharmaceuticals and Cipla Pharmaceuticals of India signed an exclusive license agreement in China for esomeprazole magnesium enteric-coated dry suspension in October 2020, and the application for the import of imitation marketing was undertaken by CDE in April 2021.
Currently under review and approval
.
Zhejiang Erying Pharmaceuticals | Zhejiang Jianfeng Pharmaceuticals, Shanghai Ambisheng Pharmaceutical Technology | Qingdao Baiyang Pharmaceuticals have submitted three types of generic listing applications in domestic pharmaceutical companies.
After Osaikang and Yuandong entered the market, the domestic The dispute over the first imitation has become more fierce, and we will wait and see whether the imported imitation will be approved first or the domestic first imitation will appear first
.
Currently under review and approval
.
Zhejiang Erying Pharmaceuticals | Zhejiang Jianfeng Pharmaceuticals, Shanghai Ambisheng Pharmaceutical Technology | Qingdao Baiyang Pharmaceuticals have submitted three types of generic listing applications in domestic pharmaceutical companies.
After Osaikang and Yuandong entered the market, the domestic The dispute over the first imitation has become more fierce, and we will wait and see whether the imported imitation will be approved first or the domestic first imitation will appear first
.
In addition, it is worth noting that Esomeprazole Magnesium Enteric-coated Dry Suspension is expected to become Yuandong Bio's first drug in the field of anti-peptic ulcer
.
.
Source: CDE official website, Minet database
Statistics are as of December 1.
Please correct me if there are any errors or omissions
.
Please correct me if there are any errors or omissions
.
